Canadian contract manufacturer QSV Biologics has signed two
manufacturing deals in as many weeks, strengthening its position in
the Phase II and III clinical supplies arena.
There are currently three key market trends that play to Parexel's
strengths and one of them is the globalisation of clinical trials,
the company's CEO claimed during a healthcare conference earlier
this month.
Covance was nothing but optimistic about the future of contract
research organisations (CROs) during a JPMorgan healthcare
conference held last week, despite a slowdown in R&D spending
over the past year.
A new study condemns the high prevalence of ghost writing in
pharmaceutical company-sponsored clinical trials and calls for the
controversial practice to be culled in order to improve
transparency.
Quintiles has teamed up with practices group Onmark to create a
national clinical trial network comprised of Onmark members - a
move that could help the CRO cope with increasing patient
recruitment issues in the US.
China is now an industry buzzword when it comes to outsourcing and
yet another report adds to the list of research recently published
that give evidence of the increasing popularity of the country as a
location to conduct drug clinical...
Singapore is planning to double the number of clinical trials it
runs over the next five year, particularly in early phase research,
as it looks to hold its ground amidst industry explosion in the
Asia Pacific.
The booming pharmaceutical contract research market sees a new
player enter the arena as analytical lab Eno River Labs separates
into two independent divisions to create a new business that will
provide analytical and formulation...
Helix BioPharma and BioVectra have signed a deal for the
manufacture of Helix's new lung cancer drug for clinical trials - a
move that strengthens the already existing relationship between the
two Canadian firms.
Despite the many challenges facing the pharma industry, drug
developers should be optimistic, and one of the reasons is the
increasing reliance on global outsourcing to speed development and
reduce costs, says new report.
DSM Pharmaceuticals is showing no sign of slowing down as it
continues to invest in the expansion of its pharmaceutical
production capabilities - the latest being the completion of a
revamped sterile parenteral manufacturing plant...
Quintiles has formed a new alliance with a hospital near its
headquarters in North Carolina, from where it has begun running
clinical trials on experimental drugs.
Ciphergen has hired contract research organization (CRO)
PrecisionMed to help it with upcoming clinical trials for its
experimental ovarian cancer tests.
In the next one to two years there will be a trend towards
significant reductions in clinical outsourcing/contract research
organisation (CRO) budgets in the majority of biopharma firms,
reveals a recent industry survey.
i3 has announced new plans to expand its pharmaceutical services
offerings across four continents - India, Latin America, and
Eastern and Western Europe.
AAIPharma has announced it has signed a contract manufacturing
agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims
to provide a "one-stop drug development solution" for drug makers.
The contract research organisation (CRO) industry is in full swing
as the clinical trial outsourcing trend continues, but where is the
money being spent?
A new contract research organization (CRO) has opened in Hong Kong
and will be the only clinical trial site outside of China with the
approval of China's State Food and Drug Administration (SFDA) to
run oncology trials.
Charles River Laboratories is the latest in a series of large
contract research organisations making acquisitions to beef up
their Phase I capacity as this market sector remains hot.
Pharma companies that aren't maximising their outsourcing potential
in clinical research may be wasting a world of opportunity.
OutsourcingPharma.com gives a brief run down of exactly what kinds
of services and providers are...
PPD managed a net revenue of $313.1m (€250m) for the third quarter
of 2006, an increase of 14.6 per cent over net revenue of $273.3m
for the third quarter of 2005. This has been buoyed on by the
strong performance by the company's...
As it steps up its presence in the major clinical trials
recruitment hubs in Asia, Quintiles has announced its intention to
open a central lab in India to help feed its expanding network of
clinical trial operations in the country.
As the clinical trial activities continue to flock towards emerging
countries such as India, Morocco wants its share has been making
efforts to make itself attractive to international trial sponsors.
Paraxel has acquired a $65m (€52m) US business that will inflate
its early phase capacity enough to make it one of the largest
providers of Phase I services in the world and help "return its US
operations to profitability".
Falling foul of the patient recruitment problems that are plaguing
the industry, RegeneRx Biopharmaceuticals has recruited an
undisclosed contract research organisation (CRO) to help it with
the mountainous task.
After opening its first large scale clinical research facility
earlier this year in the US through its new clinical research
division, Qualia Clinical Service, Holmes Biopharma is starting to
see the business gain momentum.
AAIPharma is showing the first signs of life after bankruptcy,
buying its first company after emerging from the ordeal - a
French-based clinical research organisation (CRO).
A new firm called Clinical Conduct Associates has been launched in
Ireland in the hope of attracting new clinical research business to
this "underutilised region" from pharmaceutical companies
throughout Europe.
Australia's AtCor Medical will supply an undisclosed US
pharmaceutical company with central blood pressure reading and
clinical trial support services in a deal worth $1.48m (€1.2m).
US blood products and services provider HemaCare has added a new
research segment to the company with the acquisition of private US
firm Teragenix for $4.8m (€3.7m).
Large global contract research organisation, SFBC International,
has changed its name to PharmaNet Development Group in a bid to
make a fresh start and turnaround the troubled business after a
long period of bad press, legal difficulties...
California-based Synteract has scored a clinical trial management
contract from Northwest Biotherapeutics to bring one of the world's
first personalised medicines into a late stage clinical trial.
PPD International has launched a new software system that it claims
can speed up the review time of safety and endpoint-driven data
from large-scale clinical trials or registries.
Biopharmaceutical firm Altus has asked contract manufacturer Althea
to produce Phase III quantities of a crystallised formulation of
human growth hormone (hGH) which can be administered subcutaneously
weekly instead of daily.
Contract research organisations (CROs) are slashing clinical trial
times by an average of 30 per cent and the outsourcing trend is
showing no signs of slowing, as the pharma industry continues to
face rising pressure to reduce time-to-market...
Global drug development spending will top $105bn (€81.5bn) by 2010
and 40 per cent of this business is expected to be dished out in
outsourcing contracts - with contract research organisations (CROs)
emerging triumphant.
Pharma firms may soon have the chance to use US prisoners in
clinical drug trials after a new report by a panel of medical
advisers at the Institute of Medicine recommended government laws
against the practice be loosened.
Canada's Allied Research International (ARI) has expanded its Phase
I testing capabilities in response to the continued need for extra
capacity in this area.
Covalent Group has signed a $1.7m (€1.3m) contract with a new,
undisclosed pharma firm to carry out a Phase II trial on a new drug
for atherosclerosis - a disease affecting the arterial blood
vessels throughout the body.
As global contract research spending remains robust, business is
booming for Pharmaceutical Product Development (PPD) as the US firm
reported a surge in sales, profits and new business for its second
quarter 2006.
Premier Research has strengthened its presence in the US with the
recent purchase of Philadelphia-based clinical research
organisation (CRO) Scirex Corporation.
Almac Group today announces the release of the company’s 2023 Corporate Social Responsibility report, which highlights Almac’s progress and commitments...
It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...
The use of internal standards (IS) is essential for developing and applying liquid chromatography-tandem mass spectrometric (LC-MS/MS) quantitative bioanalytical...